» Articles » PMID: 35329031

Post-Discharge Depression Status for Survivors of Extracorporeal Membrane Oxygenation (ECMO): Comparison of Veno-Venous ECMO and Veno-Arterial ECMO

Overview
Publisher MDPI
Date 2022 Mar 25
PMID 35329031
Authors
Affiliations
Soon will be listed here.
Abstract

Extracorporeal membrane oxygenation (ECMO) is one of the common invasive treatments for the care of critically ill patients with heart failure, respiratory failure, or both. There are two modes of ECMO, namely, veno-venous (VV) and veno-arterial (VA), which have different indications, survival rates, and incidences of complications. This study's aim was to examine whether depression status differed between patients who had received VV-ECMO or VA-ECMO and had been discharged from the hospital. This was a descriptive, cross-sectional, and correlational study of patients who had been discharged from the hospital at least one month after receiving ECMO at a medical center in northern Taiwan from June 2006 to June 2020 ( = 142). Participants were recruited via convenience and quota sampling. Data were collected in the cardiovascular outpatient department between October 2015-October 2016 ( = 52) and September 2019-August 2020 ( = 90). Participants completed the Hospital Anxiety and Depression Scale-Depression (HADS-D) as a measure of depression status. Post-discharge depression scores for patients who received VV-ECMO ( = 67) was significantly higher ( = 0.018) compared with participants who received VA-ECMO ( = 75). In addition, the mode of ECMO was a predictor of post-discharge depression ( = 0.008) for participants who received VV-ECMO. This study concluded that patients who received VV-ECMO may require greater mental health support. Healthcare professionals should establish a psychological clinical care pathway evaluated by multiple healthcare professionals.

Citing Articles

Long-term outcomes of patients supported with extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.

Turgeon J, Venkatamaran V, Englesakis M, Fan E Intensive Care Med. 2024; 50(3):350-370.

PMID: 38197932 DOI: 10.1007/s00134-023-07301-7.

References
1.
Bein T, Weber-Carstens S, Apfelbacher C . Long-term outcome after the acute respiratory distress syndrome: different from general critical illness?. Curr Opin Crit Care. 2017; 24(1):35-40. PMC: 5757654. DOI: 10.1097/MCC.0000000000000476. View

2.
Pizzagalli D, Roberts A . Prefrontal cortex and depression. Neuropsychopharmacology. 2021; 47(1):225-246. PMC: 8617037. DOI: 10.1038/s41386-021-01101-7. View

3.
Worsham C, Banzett R, Schwartzstein R . Dyspnea, Acute Respiratory Failure, Psychological Trauma, and Post-ICU Mental Health: A Caution and a Call for Research. Chest. 2020; 159(2):749-756. PMC: 7528739. DOI: 10.1016/j.chest.2020.09.251. View

4.
Mirabel M, Luyt C, Leprince P, Trouillet J, Leger P, Pavie A . Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med. 2011; 39(5):1029-35. DOI: 10.1097/CCM.0b013e31820ead45. View

5.
Neufeld K, Leoutsakos J, Yan H, Lin S, Zabinski J, Dinglas V . Fatigue Symptoms During the First Year Following ARDS. Chest. 2020; 158(3):999-1007. PMC: 7478232. DOI: 10.1016/j.chest.2020.03.059. View